HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B P L Wijnhoven Selected Research

Obesity

11/2010Prognostic value of body mass index on short-term and long-term outcome after resection of esophageal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B P L Wijnhoven Research Topics

Disease

37Neoplasms (Cancer)
07/2022 - 05/2004
11Adenocarcinoma
07/2022 - 02/2004
10Esophageal Neoplasms (Esophageal Cancer)
07/2022 - 11/2008
6Stomach Neoplasms (Stomach Cancer)
12/2019 - 07/2016
2Neoplasm Metastasis (Metastasis)
12/2019 - 03/2015
2Carcinoma (Carcinomatosis)
12/2019 - 05/2018
2Weight Loss (Weight Reduction)
05/2018 - 01/2018
2Barrett Esophagus (Barrett's Esophagus)
01/2018 - 06/2010
2Margins of Excision
05/2015 - 05/2012
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2014 - 11/2008
1Flatulence
06/2021
1Vomiting
04/2020
1Nausea
04/2020
1Disease Progression
05/2019
1Sarcoma (Soft Tissue Sarcoma)
03/2018
1Abscess
01/2018
1Appendicitis
01/2018
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
12/2017
1Carcinogenesis
09/2017
1Anastomotic Leak
01/2017
1Fistula
01/2016
1Neutropenia
05/2012
1Leukopenia
05/2012
1Fatigue
05/2012
1Anorexia
05/2012
1Lymphatic Metastasis
11/2010
1Obesity
11/2010
1Overweight
11/2010
1Metaplasia
06/2010
1Neoplastic Processes
06/2010
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
02/2004

Drug/Important Bio-Agent (IBA)

2human ERBB2 proteinIBA
07/2022 - 05/2015
2MicroRNAs (MicroRNA)IBA
06/2010 - 01/2007
1NivolumabIBA
07/2022
1Trastuzumab (Herceptin)FDA Link
07/2022
1LigandsIBA
07/2022
1Blocking AntibodiesIBA
07/2022
1Immune Checkpoint InhibitorsIBA
07/2022
1CTLA-4 AntigenIBA
07/2022
1pembrolizumabIBA
07/2022
1Oxygen (Dioxygen)IBA
06/2021
1BariumIBA
04/2020
1ORALIT (ORS)IBA
05/2018
1Indicators and Reagents (Reagents)IBA
05/2018
1Anti-Bacterial Agents (Antibiotics)IBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
09/2017
1Biocompatible Materials (Biomaterials)IBA
07/2016
1Surface Antigens (Surface Antigen)IBA
08/2012
1Paclitaxel (Taxol)FDA LinkGeneric
05/2012
1Carboplatin (JM8)FDA LinkGeneric
05/2012
1RNA (Ribonucleic Acid)IBA
06/2010
1Proteins (Proteins, Gene)FDA Link
01/2007
1Messenger RNA (mRNA)IBA
01/2007
1CateninsIBA
05/2004
1Cadherins (E-Cadherin)IBA
05/2004
1TCF Transcription FactorsIBA
02/2004
1beta-Transducin Repeat-Containing ProteinsIBA
02/2004
1beta CateninIBA
02/2004

Therapy/Procedure

24Neoadjuvant Therapy
07/2022 - 11/2008
14Esophagectomy
04/2020 - 04/2009
6Therapeutics
07/2022 - 11/2010
6Chemoradiotherapy
01/2019 - 11/2008
4Drug Therapy (Chemotherapy)
07/2022 - 01/2018
3Gastrectomy
12/2019 - 05/2019
2Lymph Node Excision (Lymph Node Dissection)
10/2016 - 11/2010
2Induction Chemotherapy
03/2015 - 07/2009
1Palliative Care (Palliative Therapy)
07/2022
1Immunotherapy
07/2022
1Metastasectomy
12/2019
1Pancreatectomy
12/2019
1Cytoreduction Surgical Procedures
05/2019
1Hyperthermic Intraperitoneal Chemotherapy
05/2019
1Laparotomy
05/2019
1Antibiotic Prophylaxis
01/2018
1Adjuvant Chemoradiotherapy
11/2017
1Adjuvant Chemotherapy
11/2017
1Organ Sparing Treatments
01/2017
1Combined Modality Therapy
07/2016
1Radiofrequency Ablation
01/2016
1Radiotherapy
05/2012
1Aftercare (After-Treatment)
11/2008